National regulatory authorities have granted emergency use authorizations for twenty-four COVID-19 vaccines. Six of those have been approved for emergency or full use by at least one WHO-recognized stringent regulatory authority (Oxford–AstraZeneca, Pfizer-BioNTech, Sinopharm-BBIBP, Moderna, Sinovac, and Janssen).
For COVID-19 vaccination policy by country, see Vaccination policy § Table.
Overview maps.
|
Comments are closed.